No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
CMCO240719P45000
- 2.35
- 0.000.00%
15min DelayTrading May 29 11:38 ET
0.00High0.00Low
0.00Open2.35Pre Close0 Volume1 Open Interest45.00Strike Price0.00Turnover170.27%IV-14.80%PremiumJul 19, 2024Expiry Date7.85Intrinsic Value100Multiplier3DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8554Delta0.0368Gamma4.50Leverage Ratio-0.1885Theta-0.0033Rho-3.85Eff Leverage0.0083Vega
Intraday
- 5D
- Daily
News
Earnings Are Growing at Columbus McKinnon (NASDAQ:CMCO) but Shareholders Still Don't Like Its Prospects
For many investors, the main point of stock picking is to generate higher returns than the overall market. But its virtually certain that sometimes you will buy stocks that fall short of the market a
Q1 Earnings Outperformers: Columbus McKinnon (NASDAQ:CMCO) And The Rest Of The General Industrial Machinery Stocks
Columbus McKinnon Publishes Fourth Annual Corporate Sustainability Report
Columbus McKinnon Corporation (NASDAQ:CMCO) ("Columbus McKinnon" or the "Company), a leading designer and manufacturer of intelligent motion solutions, products and technologies for material handling, today announced
Columbus McKinnon to Present at the Wells Fargo 2024 Industrials Conference
Columbus McKinnon Corporation (NASDAQ:CMCO) ("Columbus McKinnon" or the "Company"), today announced that it will present at the Wells Fargo 2024 Industrials Conference on June 11, 2024, at approximately 3:15 p.m.
Columbus McKinnon Initiated at Overweight by JP Morgan
Columbus McKinnon Initiated at Overweight by JP Morgan
Columbus McKinnon Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/04/2024 41.41% JP Morgan → $53 Initiates Coverage On → Overweight 02/05/2024 33.4% DA Davidson $48 → $5
Comments
Insider's sale of shares at a lower price may suggest belief in the stock's full valuation. However, this is a weak sign and doesn't definitively indicate their view on the stock's value. The lack of insider buying recently and history of sales make us cautious about the stock.
Senior Vice President of Global Product Development & Marketing Mario Ramos Lara Sold A Bunch Of Shares In Columbus McKinnonColumbus McKinnon's high P/E compared to the market appears justified due to expected earnings growth and potential EPS increase. This is anticipated to strongly support the share price, barring changes in circumstances.
BOFA
• $Oscar Health(OSCR.US$ BofA analyst Kevin Fischbeck downgraded Oscar Health to Neutral from Buy with a price target of $6, down from $12. The analyst sees greater medical loss ratio uncertainty into 2023. The industry is going to have to manage through the expiration of the expanded Affordable Care Act subsidies, Medicaid redeterminations and the result shift within the risk pool making it more difficult to price, Fischb...
• $Oscar Health(OSCR.US$ BofA analyst Kevin Fischbeck downgraded Oscar Health to Neutral from Buy with a price target of $6, down from $12. The analyst sees greater medical loss ratio uncertainty into 2023. The industry is going to have to manage through the expiration of the expanded Affordable Care Act subsidies, Medicaid redeterminations and the result shift within the risk pool making it more difficult to price, Fischb...
31
Upgrades
• $AmerisourceBergen(ABC.US$ : Barclays Upgrades to Overweight from Equalweight - PT $182 (from $175)
• $Alignment Healthcare(ALHC.US$ : BofA Securities Upgrades to Buy from Neutral - PT $14 (from $18)
• $The Cigna Group(CI.US$ : BofA Securities Upgrades to Neutral from Underperform - PT $300 (from $265)
• $Canadian National Railway(CNI.US$ : Evercore ISI Upgrades to Outperform from In Line
• $Youdao(DAO.US$ : Citic Securities Upgrades to Buy from Neut...
• $AmerisourceBergen(ABC.US$ : Barclays Upgrades to Overweight from Equalweight - PT $182 (from $175)
• $Alignment Healthcare(ALHC.US$ : BofA Securities Upgrades to Buy from Neutral - PT $14 (from $18)
• $The Cigna Group(CI.US$ : BofA Securities Upgrades to Neutral from Underperform - PT $300 (from $265)
• $Canadian National Railway(CNI.US$ : Evercore ISI Upgrades to Outperform from In Line
• $Youdao(DAO.US$ : Citic Securities Upgrades to Buy from Neut...
6
1
Read more